Gene therapy, stem cell therapy, CAR T, cell therapy, and gene editing are all forms of genomic medicine1 - an approach to cure and treat human diseases that uses human biology rather than chemical compounds made in the lab.
The ability to consistently bring treatments and cures to market depends upon a company’s capacity to create and sustain a successful product development pipeline.
Historically, developing rare disease cures and treatments has been challenging. The small, globally dispersed patient population made it difficult and […]
These five biotechnology companies in Maryland may make history in 2021 because they have multiple therapeutic programs in trials for […]
Pharmaceutical companies have been developing therapies to treat or prevent disease since the end of the 19th century. Chemical compounds […]